The hyper-intensified process delivers significant increases in AAV yield and full capsid percentage through a novel adherent, perfusion-based manufacturing approach PHILADELPHIA, May 15, ...
PHILADELPHIA--(BUSINESS WIRE)--VintaBio, a biotech manufacturer specializing in high-yield, high-purity viral vectors for gene therapy, today presented data further demonstrating the advantages and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results